Dual-Responsive Nanozyme Reactor Based on Hollow MnO2 on Upconversion Nanoparticles for Targeted Hepatocellular Carcinoma Therapy
ACS Applied Nano Materials · 31.07.2026 · 9 (30) · 14209-14222
DOI: 10.1021/acsanm.6c01731 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Nano Materials, online erschienen am 16.07.2026. Verfasst von Hui Li und 6 weiteren Autor:innen. Die Arbeit nennt 59 Literaturangaben. Gefördert von: Natural Science Foundation of Chongqing Municipality.
Abstract (Originalsprache)
Hepatocellular carcinoma (HCC) remains a significant therapeutic challenge due to multiple bottlenecks, including low early diagnosis rates, rapid disease progression, and limited efficacy of monotherapy. Against this backdrop, multimodal integrated treatment has emerged as a core solution. Here, we reported a tumor-microenvironment (TME)-activatable “nano-cocktail” (UMDCAc) that synchronizes photodynamic (PDT), chemodynamic (CDT), and starvation (ST) therapies for synergistic HCC eradication. UMDCAc was engineered by growing hollow MnO2 (HMnO2) on upconversion nanoparticles (UCNPs), coloading dihydroartemisinin (DHA) and the photosensitizer chlorin e6 (Ce6), and in situ anchoring ultrasmall gold nanoparticles (AuNPs) that mimic glucose oxidase (GOx). Surface modification with cyclic RGD peptides enabled active targeting of αvβ3 integrin. The targeting strategy synergizes with near-infrared (NIR) light-activated catalysis to enhance therapeutic efficacy. Invitro and invivo data demonstrate that UMDCAc achieves tumor suppression through synergistically amplified reactive oxygen species (ROS) generation, hypoxia relief, and targeted delivery, while maintaining favorable biocompatibility and safety and exhibiting superior efficacy over monotherapy. The synergistically generated ROS compromise cellular antioxidant defenses, induce lipid peroxidation, and double the apoptosis rate, thereby producing effective antitumor effects. Therefore, this innovative multimodal strategy offers opportunities for collaborative cancer therapy.
Förderung
- Natural Science Foundation of Chongqing Municipality
Zitieren
APA
Li, H., Fan, J., Liao, J., Chen, K., Tang, Q., Tang, H., & Wang, D. (2026). Dual-Responsive Nanozyme Reactor Based on Hollow MnO2 on Upconversion Nanoparticles for Targeted Hepatocellular Carcinoma Therapy. ACS Applied Nano Materials, 9(30), 14209-14222. https://doi.org/10.1021/acsanm.6c01731
Vancouver
Li H, Fan J, Liao J, Chen K, Tang Q, Tang H, et al. Dual-Responsive Nanozyme Reactor Based on Hollow MnO2 on Upconversion Nanoparticles for Targeted Hepatocellular Carcinoma Therapy. ACS Applied Nano Materials. 2026;9(30):14209-14222. doi:10.1021/acsanm.6c01731
BibTeX
@article{Li2026,
author = {Li, Hui and Fan, Jingnan and Liao, Jiamei and Chen, Ke and Tang, Qingxia and Tang, Hua and Wang, Dan},
title = {Dual-Responsive Nanozyme Reactor Based on Hollow MnO2 on Upconversion Nanoparticles for Targeted Hepatocellular Carcinoma Therapy},
journal = {ACS Applied Nano Materials},
year = {2026},
volume = {9},
number = {30},
pages = {14209--14222},
doi = {10.1021/acsanm.6c01731}
}
EUVIMED